These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2409872

  • 1. Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia.
    Nienhuis AW, Ley TJ, Humphries RK, Young NS, Dover G.
    Ann N Y Acad Sci; 1985; 445():198-211. PubMed ID: 2409872
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H, Sutton M, Atweh GF.
    Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
    [Abstract] [Full Text] [Related]

  • 3. Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
    Dover GJ, Charache S, Nora R, Boyer SH.
    Ann N Y Acad Sci; 1985; 445():218-24. PubMed ID: 2409873
    [No Abstract] [Full Text] [Related]

  • 4. Induction of hemoglobin F synthesis in patients with beta thalassemia.
    Ley TJ, Nienhuis AW.
    Annu Rev Med; 1985; 36():485-98. PubMed ID: 2581500
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors.
    Cao H.
    Hematology; 2004 Jun; 9(3):223-33. PubMed ID: 15204104
    [Abstract] [Full Text] [Related]

  • 7. Reactivation of fetal hemoglobin in patients with beta-thalassemia.
    Olivieri NF.
    Semin Hematol; 1996 Jan; 33(1):24-42. PubMed ID: 8714583
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA.
    Adv Pediatr; 1996 Jan; 43():309-34. PubMed ID: 8794181
    [No Abstract] [Full Text] [Related]

  • 9. Augmentation of hemoglobin synthesis by S-phase specific drugs in the K562 cell line.
    Dean A, Wu YJ, Ley T, Fordis CM, Schechter AN.
    Prog Clin Biol Res; 1985 Jan; 191():205-16. PubMed ID: 2413473
    [No Abstract] [Full Text] [Related]

  • 10. Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment.
    Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.
    Ann N Y Acad Sci; 2005 Jan; 1054():250-6. PubMed ID: 16339672
    [Abstract] [Full Text] [Related]

  • 11. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ, Charache S, Boyer SH.
    Trans Assoc Am Physicians; 1984 Jan; 97():140-5. PubMed ID: 6085527
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacologic manipulation of fetal hemoglobin synthesis.
    Dover GJ, Humphries RK, Young N, Ley T, Boyer S, Charache S, Nienhuis A.
    Prog Clin Biol Res; 1985 Jan; 191():447-54. PubMed ID: 2413480
    [Abstract] [Full Text] [Related]

  • 13. Approaches to the reactivation of hemoglobin F as a treatment for sickle cell disease.
    DeSimone J.
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):23-4. PubMed ID: 16163154
    [No Abstract] [Full Text] [Related]

  • 14. 5-azacytidine for beta-thalassaemia?
    Lancet; 1983 Jan 01; 1(8314-5):36-7. PubMed ID: 6184580
    [No Abstract] [Full Text] [Related]

  • 15. 5-azacytidine for beta thalassaemia?
    Ley TJ, Anagnou NP, Young NS, Nienhuis AW, DeSimone J, Heller P.
    Lancet; 1983 Feb 26; 1(8322):467. PubMed ID: 6186873
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
    Yang YM, Pace B.
    Pediatr Pathol Mol Med; 2001 Feb 26; 20(1):87-106. PubMed ID: 12673846
    [Abstract] [Full Text] [Related]

  • 17. The role of fetal hemoglobin-enhancing agents in thalassemia.
    Lal A, Vichinsky E.
    Semin Hematol; 2004 Oct 26; 41(4 Suppl 6):17-22. PubMed ID: 15534853
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hemoglobin switching protocols in thalassemia. Experience with sodium phenylbutyrate and hydroxyurea.
    Dover GJ.
    Ann N Y Acad Sci; 1998 Jun 30; 850():80-6. PubMed ID: 9668530
    [Abstract] [Full Text] [Related]

  • 20. Pharmacologic manipulation of fetal hemoglobin. Update on clinical trials with hydroxyurea.
    Dover GJ.
    Ann N Y Acad Sci; 1990 Jun 30; 612():184-90. PubMed ID: 1705407
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.